Heres why: 1
BMJ 29(372):n71 Crocker TF, Lam N, Jordo M, Brundle C, Prescott M, Forster A et al (2023) Risk-of-bias assessment using Cochranes revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review
Combination trials with GLP-1/GIP agents are in progress, although functional endpoints and long-term safety remain insufficiently defined
these drugs should not be used in patients with a personal or family history of medullary thyroid carcinoma or MEN2 Rare cases of retinopathy progression in patients with pre-existing severe diabetic retinopathy, likely related to rapid glycemic improvement Potential drug interactions related to delayed gastric emptying, which can affect absorption of other oral medications The practical approach is dose titration
Around a decade ago, having shifted to a multi-level marketing model, LifeVantage began to ramp up spurious claims about the power of its natural compounds to halt or reverse effects not only of the aging process, but of conditions including cancer and Alzheimers